share_log

Ginkgo Bioworks: Ginkgo Bioworks Holdings, Inc. - Reverse Split Option Symbol: DNA New Symbol: DNA1

Ginkgo Bioworks: Ginkgo Bioworks Holdings, Inc. - Reverse Split Option Symbol: DNA New Symbol: DNA1

Ginkgo Bioworks：银杏生物工程控股公司 - 反向拆股选择
标的代码: DNA 新代码: DNA1
OCC期权清算公司 ·  08/19 11:59
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc., known by its stock symbol DNA, has announced a reverse stock split that will take effect on August 20, 2024. The reverse split will be conducted at a ratio of 1-for-40, resulting in a change of the company's option symbol from DNA to DNA1. Following the split, the new multiplier for options will be set at 100, and the new deliverable per contract will include 2 new Class A Common Shares of Ginkgo Bioworks and cash in lieu of 0.5 fractional shares. The cash portion of the deliverable will be settled once the cash in lieu amount is determined, with the DNA component settling through the National Securities Clearing Corporation (NSCC). The Options Clearing Corporation (OCC) will oversee the settlement of the cash portion and the adjustment of options and futures as per their by-laws.
Ginkgo Bioworks Holdings, Inc., known by its stock symbol DNA, has announced a reverse stock split that will take effect on August 20, 2024. The reverse split will be conducted at a ratio of 1-for-40, resulting in a change of the company's option symbol from DNA to DNA1. Following the split, the new multiplier for options will be set at 100, and the new deliverable per contract will include 2 new Class A Common Shares of Ginkgo Bioworks and cash in lieu of 0.5 fractional shares. The cash portion of the deliverable will be settled once the cash in lieu amount is determined, with the DNA component settling through the National Securities Clearing Corporation (NSCC). The Options Clearing Corporation (OCC) will oversee the settlement of the cash portion and the adjustment of options and futures as per their by-laws.
Ginkgo Bioworks Holdings, Inc.宣布股票代码为DNA的标的将于2024年8月20日进行股票拆分。该反向股票拆分将以1：40的比例进行，导致公司期权代码从DNA更改为DNA1。在拆分后，期权的新乘数将设置为100，并且每个合同的新可交付物包括2个新的Ginkgo Bioworks Class A普通股及0.5碎股的等值现金补偿。可交付物的现金部分将在确定等值现金补偿金额后结算，DNA部分通过全国证券结算公司NSCC结算。期权交易结算所（OCC）将根据相关规章制度监督现金结算部分和期权、期货的调整。
Ginkgo Bioworks Holdings, Inc.宣布股票代码为DNA的标的将于2024年8月20日进行股票拆分。该反向股票拆分将以1：40的比例进行，导致公司期权代码从DNA更改为DNA1。在拆分后，期权的新乘数将设置为100，并且每个合同的新可交付物包括2个新的Ginkgo Bioworks Class A普通股及0.5碎股的等值现金补偿。可交付物的现金部分将在确定等值现金补偿金额后结算，DNA部分通过全国证券结算公司NSCC结算。期权交易结算所（OCC）将根据相关规章制度监督现金结算部分和期权、期货的调整。
有用
没用

该公告为独立文件：

独立文件1

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息